-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, approved the addition of 1ml: 0.1 g specifications to this product and passed the consistent evaluation of generic drug quality and efficacy (“consistency evaluation”). This medicine is suitable for the prevention and treatment of vitamin Bdeficiency.

Zhitongcaijing·08/14/2026 07:57:01
Listen to the news
Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, approved the addition of 1ml: 0.1 g specifications to this product and passed the consistent evaluation of generic drug quality and efficacy (“consistency evaluation”). This medicine is suitable for the prevention and treatment of vitamin Bdeficiency.